oxidopamine has been researched along with Glioma in 7 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giuliani, P | 1 |
| Ballerini, P | 1 |
| Buccella, S | 1 |
| Ciccarelli, R | 1 |
| Rathbone, MP | 1 |
| Romano, S | 1 |
| D'Alimonte, I | 1 |
| Caciagli, F | 1 |
| Di Iorio, P | 1 |
| Pokorski, M | 1 |
| Massie, A | 1 |
| Schallier, A | 1 |
| Kim, SW | 1 |
| Fernando, R | 1 |
| Kobayashi, S | 1 |
| Beck, H | 1 |
| De Bundel, D | 1 |
| Vermoesen, K | 1 |
| Bannai, S | 1 |
| Smolders, I | 1 |
| Conrad, M | 1 |
| Plesnila, N | 1 |
| Sato, H | 1 |
| Michotte, Y | 1 |
| Zhang, Y | 1 |
| Schlachetzki, F | 1 |
| Zhang, YF | 1 |
| Boado, RJ | 1 |
| Pardridge, WM | 1 |
| Mazzio, EA | 1 |
| Kolta, MG | 1 |
| Reams, RR | 1 |
| Soliman, KF | 1 |
| Zuo, D | 1 |
| Yu, PH | 1 |
| Trejo, F | 1 |
| Vergara, P | 1 |
| Brenner, M | 1 |
| Segovia, J | 1 |
| Bing, G | 1 |
| Notter, MF | 1 |
| Hansen, JT | 1 |
| Kellogg, C | 1 |
| Kordower, JH | 1 |
| Gash, DM | 1 |
7 other studies available for oxidopamine and Glioma
| Article | Year |
|---|---|
Guanosine protects glial cells against 6-hydroxydopamine toxicity.
Topics: Animals; Apoptosis; Astrocytes; Biological Transport; Butadienes; Cell Line, Tumor; Chromones; DNA F | 2015 |
Dopaminergic neurons of system x(c)⁻-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity.
Topics: Aging; Amino Acid Transport System y+; Animals; Corpus Striatum; Cystine; Dopamine; Glioma; Glutamic | 2011 |
Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter.
Topics: Animals; Antibodies, Monoclonal; Blood-Brain Barrier; Cell Nucleus; Central Nervous System Neoplasms | 2004 |
Inhibitory effects of cigarette smoke on glial inducible nitric oxide synthase and lack of protective properties against oxidative neurotoxins in vitro.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Cell Survival; Glioma; Hydrogen Peroxide; Monoamine Ox | 2005 |
Increase of survival of dopaminergic neuroblastoma in co-cultures with C-6 glioma by R-(-)-deprenyl.
Topics: Brain Neoplasms; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Glioma; Humans; Neurobla | 1995 |
Gene therapy in a rodent model of Parkinson's disease using differentiated C6 cells expressing a GFAP-tyrosine hydroxylase transgene.
Topics: Animals; Cell Transplantation; Genetic Therapy; Glial Fibrillary Acidic Protein; Glioma; Humans; Mal | 1999 |
Cografts of adrenal medulla with C6 glioma cells in rats with 6-hydroxydopamine-induced lesions.
Topics: Adrenal Medulla; Catecholamines; Corpus Striatum; Glioma; Graft Survival; Hydroxydopamines; Immunohi | 1990 |